IDEXX LABORATORIES INC /DE (IDXX) FY2026 Q1 Balance Sheet
As of 2026-03-31
Balance Sheet
As of 2026-03-31
Swipe to see the full flow
Chart details
IDEXX LABORATORIES INC /DE (IDXX) FY2026 Q1 Balance Sheet
Balance sheet as of 2026-03-31. The chart shows assets, liabilities and equity at that date.
- Assets
- 3,385,497,000 US dollars
- Current assets
- 1,454,075,000 US dollars
- Non-current assets
- 1,931,422,000 US dollars
- Liabilities
- 1,829,394,000 US dollars
- Current liabilities
- 1,299,851,000 US dollars
- Non-current liabilities
- 529,543,000 US dollars
- Equity
- 1,556,103,000 US dollars
- Accounts receivable, net
- 603,544,000 US dollars
- Inventories
- 382,400,000 US dollars
- Other current assets
- 267,603,000 US dollars
- Cash and cash equivalents
- 200,528,000 US dollars
- Property and equipment, net
- 740,382,000 US dollars
- Other long-term assets
- 552,791,000 US dollars
- Goodwill
- 412,104,000 US dollars
- Operating lease right-of-use assets
- 121,395,000 US dollars
- Intangible assets, net
- 104,750,000 US dollars
- Credit facility
- 530,000,000 US dollars
- Accrued liabilities
- 453,552,000 US dollars
- Current portion of long-term debt
- 149,997,000 US dollars
- Accounts payable
- 129,974,000 US dollars
- Current portion of deferred revenue
- 36,328,000 US dollars
- Long-term debt, net of current portion
- 299,854,000 US dollars
- Long-term operating lease liabilities, net of current portion
- 98,747,000 US dollars
- Other long-term liabilities
- 54,034,000 US dollars
- Deferred income tax liabilities
- 44,595,000 US dollars
- Long-term deferred revenue, net of current portion
- 32,313,000 US dollars
- Retained earnings
- 6,670,348,000 US dollars
- Additional paid-in capital
- 1,861,079,000 US dollars
- Common stock, $0.10 par value: Authorized: 120,000 shares; Issued: 108,500 shares in 2026 and 108,369 shares in 2025; Outstanding: 79,240 shares in 2026 and 79,712 shares in 2025
- 10,850,000 US dollars
- Deferred stock units: Outstanding: 60 units in 2026 and 59 units in 2025
- 6,169,000 US dollars
- Treasury stock, at cost: 29,261 shares in 2026 and 28,657 shares in 2025
- negative 6,927,403,000 US dollars
- Accumulated other comprehensive loss
- negative 64,940,000 US dollars
- Gross equity (calculated)
- 8,548,446,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.
Chart connections
- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
